Interpace Biosciences, Inc. (IDXG)
6.025
-0.36
(-5.71%)
USD |
OTCM |
Oct 02, 16:00
Interpace Biosciences Profit Margin (Quarterly) : 2.91% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.91% |
| March 31, 2026 | 9.20% |
| December 31, 2025 | |
| September 30, 2025 | 11.55% |
| June 30, 2025 | -5.77% |
| March 31, 2025 | 15.23% |
| December 31, 2024 | 15.03% |
| September 30, 2024 | 14.30% |
| June 30, 2024 | 20.85% |
| March 31, 2024 | 7.98% |
| December 31, 2023 | 9.79% |
| September 30, 2023 | -5.82% |
| June 30, 2023 | 3.58% |
| March 31, 2023 | 4.38% |
| December 31, 2022 | -16.89% |
| September 30, 2022 | -15.31% |
| June 30, 2022 | -41.57% |
| March 31, 2022 | -21.13% |
| December 31, 2021 | -19.12% |
| September 30, 2021 | -16.37% |
| June 30, 2021 | -30.37% |
| March 31, 2021 | -42.24% |
| December 31, 2020 | -83.84% |
| September 30, 2020 | -74.79% |
| June 30, 2020 | -101.2% |
| Date | Value |
|---|---|
| March 31, 2020 | -70.97% |
| December 31, 2019 | -253.9% |
| September 30, 2019 | -95.64% |
| June 30, 2019 | -85.63% |
| March 31, 2019 | -55.94% |
| December 31, 2018 | -71.70% |
| September 30, 2018 | -52.29% |
| June 30, 2018 | -34.05% |
| March 31, 2018 | -65.36% |
| December 31, 2017 | -113.4% |
| September 30, 2017 | -80.60% |
| June 30, 2017 | -162.2% |
| March 31, 2017 | 53.54% |
| December 31, 2016 | |
| September 30, 2016 | -217.0% |
| June 30, 2016 | -97.26% |
| March 31, 2016 | -132.0% |
| September 30, 2015 | -13.16% |
| June 30, 2015 | -18.48% |
| March 31, 2015 | -9.77% |
| December 31, 2014 | -15.49% |
| September 30, 2014 | -14.73% |
| June 30, 2014 | -8.24% |
| March 31, 2014 | -4.82% |
| December 31, 2013 | -10.02% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| PD-Rx Pharmaceuticals, Inc. | -- |
| Medical Marijuana, Inc. | -0.89% |
| Acro Biomedical Co. Ltd. | -- |
| Stella Diagnostics, Inc. | -195.2% |
| ZeroStack Corp. | -180.2% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 185.0% |
| Return on Assets | 98.52% |
| Return on Invested Capital | 163.9% |
| Gross Profit Margin (Quarterly) | 61.91% |
| Operating Margin (Quarterly) | 3.52% |
| Return on Net Operating Assets | 235.8% |